ArticleAmerican journal of ophthalmology case reports2021
Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil).
D Jackson Coleman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2021
this papercites it